IP Library Granted Patent US 7,875,750
Granted Patent B2
US 7,875,750 · App. 12/619,651 · Granted Jan 25, 2011

Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,750
App. No.
12/619,651
Granted
Jan 25, 2011
Kind
B2
Abstract

The present invention relates to a process for preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles (I) wherein the asterisk (*) represents an asymmetric carbon and R 1 is C 1 -C 6 alkyl; their enantiomers or mixtures thereof, their solvates, hydrates or pharmaceutically acceptable salts, comprising: (a) reacting a compound (II) with a secondary amine, optionally in the presence of an acid and a solvent 1, to form an enamine; (b) optionally removing said acid and said solvent 1, and then reacting said enamine with sulfur in the presence of a solvent 2; and (c) reacting the previously obtained compound with cyanamide to obtain the compound (I). Pramipexole, a compound with dopamine D-2 agonist activity, is among the compounds (I) and is useful for the treatment of Parkinson's disease and schizophrenia.

Claims (18)

1. A compound of formula (III):

wherein:

the asterisk (*) indicates the presence of an asymmetric carbon;

R 1 is a linear or branched C 1 -C 6 alkyl group; and

R 2 and R 3 are, independently of one another, C 1 -C 3 alkyl groups, or R 2 and R 3 together form a divalent C 4 -C 5 radical, or a —CH 2 CH 2 OCH 2 CH 2 — radical, forming a cycle with the nitrogen atom to which it is attached.

2. A compound according to claim 1 , wherein R 1 is n-propyl and R 2 and R 3 together form a divalent linear C 4 radical forming a cycle with the nitrogen to which they are attached.

3. A compound of formula (IV)

wherein:

the asterisk (*) indicates the presence of an asymmetric carbon; and

R 1 is a linear or branched C 1 -C 6 alkyl group.

4. A compound according to claim 3 , wherein R 1 is an n-propyl group.

5. A process for forming an enamine of formula (III)

comprising reacting a compound of formula (II)

with a secondary amine of formula NHR 2 R 3 ,

wherein:

the asterisk (*) indicates the presence of an asymmetric carbon;

R 1 is a linear or branched C 1 -C 6 alkyl group; and

R 2 and R 3 are, independently of one another, C 1 -C 3 alkyl groups, or R 2 and R 3 together form a divalent C 4 -C 5 radical, or a —CH 2 CH 2 OCH 2 CH 2 — radical, forming a cycle with the nitrogen atom to which it is attached.

Assignments (3)
MERGER Recorded Oct 16, 2012
From: RAGACTIVES, S.L.U.
To: CRYSTAL PHARMA, S.A.U.
Reel/Frame 029138/0528 →
CHANGE OF LEGAL ENTITY Recorded Oct 16, 2012
From: RAGACTIVES, S.L.
To: RAGACTIVES, S.L.U.
Reel/Frame 029140/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2012
From: PASCUAL COCA, GUSTAVO; MARTIN JUAREZ, JORGE
To: RAGACTIVES, S.L.
Reel/Frame 029132/0303 →